The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; none of the 42 sources its claims cite is checked for support yet.
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Open accessAbstract
CONTEXT: Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials. OBJECTIVE: To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents. DESIGN, SETTING, AND PARTICIPANTS: Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n = 61) or a control treatment consisting of supportive therapy and education (n = 65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment. INTERVENTION: Comprehensive behavioral intervention. MAIN OUTCOME MEASURES: Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]). RESULTS: Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95% confidence interval {CI}, 23.1-26.3] to 17.1 [95% CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95% CI, 23.2-26.0] to 21.1 [95% CI, 19.2-23.0]) (P < .001; difference between groups, 4.1; 95% CI, 2.0-6.2) (effect size = 0.68). Significantly more children receiving behavioral intervention compared with those in the control group were rated as being very much improved or much improved on the Clinical Global Impressions-Improvement scale (52.5% vs 18.5%, respectively; P < .001; number needed to treat = 3). Attrition was low (12/126, or 9.5%); tic worsening was reported by 4% of children (5/126). Treatment gains were durable, with 87% of available responders to behavior therapy exhibiting continued benefit 6 months following treatment. CONCLUSION: A comprehensive behavioral intervention, compared with supportive therapy and education, resulted in greater improvement in symptom severity among children with Tourette and chronic tic disorder. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00218777.
Overview
CoChat Summary
TL;DR
In this randomized controlled trial of 126 children and adolescents aged 9–17 with Tourette or chronic tic disorder, a comprehensive behavioral intervention (CBIT) reduced tic severity more than supportive therapy and education over 10 weeks. Treatment gains were durable for many acute responders at 6 months.
Key findings
- CBIT reduced the Yale Global Tic Severity Scale (YGTSS) Total Tic score from 24.7 to 17.1 versus 24.6 to 21.1 for control (P<.001; effect size=0.68); behavior therapy produced a 7.6-point decrease versus a 3.5-point decline in control, a 4-point between-group difference.
- Positive treatment response on the Clinical Global Impression–Improvement scale (“very much” or “much improved”) was 52.5% (32/61) with CBIT versus 18.5% (12/65) with control (P<0.001; number-needed-to-treat=3; absolute risk reduction=34%).
- Secondary outcomes favored CBIT: YGTSS Impairment dropped 51% (25.0 to 12.2) versus 30% (23.4 to 16.4) for control (P<0.01, effect size=0.57), and Children’s Global Assessment Scale scores improved 59.0 to 69.4 versus 59.3 to 64.1 (P<.001, effect size=.64).
- Among CBIT Week 10 positive responders, 20 of 32 (62.5%) continued to show benefit; with 9 lost to follow-up, 20/23 available responders (87%) showed continued benefit at 6 months. Tic worsening was reported by 1 CBIT participant (1.6%) versus 4 control participants (6.2%).
Methods
- Two-phase, multicenter randomized controlled trial at three sites; 126 youth aged 9–17 with Tourette or chronic tic disorder of moderate or greater severity were randomized 1:1 within site, stratified by tic medication status, to 8 sessions over 10 weeks of CBIT (n=61) or a control treatment of supportive therapy and education (n=65); Phase 2 followed acute responders for 6 months with booster sessions.
- Primary outcomes were the YGTSS Total Tic Score and the Clinical Global Impression–Improvement scale, rated by independent evaluators masked to treatment assignment; secondary measures included YGTSS Impairment, Children’s Global Assessment Scale, and Parent Tic Questionnaire.
- Analysis used mixed-model repeated measures adjusted for baseline scores on the modified intent-to-treat population (at least one post-randomization visit), with fixed effects for treatment, time, site, time-by-treatment interaction, and a random participant effect; CGI-I response was compared with Mantel-Haenszel chi-square, and no adjustment was made for multiple comparisons on secondary outcomes.
Limitations
- Stated: lack of pre-medication tic severity data in children entering on stable tic medication; post-treatment follow-up did not include all children, resulting in loss of randomization and low power for between-group follow-up comparisons; no adjustment for multiple comparisons on secondary outcomes; and a sizeable number of children did not benefit.
- Stated/evident: the sample was predominantly male (78.5%) and Caucasian (84.1%), so generalizability to other demographic groups is uncertain (evident from reported baseline characteristics, not framed as a limitation by the authors).
- Evident: participants, parents, and therapists were aware of treatment assignment, with only outcome evaluators masked, so expectancy effects cannot be fully excluded, although the authors note parental expectancy was high in both groups and attrition was low.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 22 Not checked · 70 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the PST group, 6 of 12 children (50%) showed continued benefit (6 were lost to follow up).”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Treatment Durability
plainn = 12- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As shown in Table 4, Table 20 of 32 (62.5%) positive responders to CBIT continued to show benefit (9 children were lost to follow up).”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Treatment Durability
plainn = 32- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no serious adverse events.”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Adverse Events
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Parents reported high expectation for positive outcome for both treatments, and the attrition rate was low for both interventions suggesting each was acceptable and well tolerated by children and families.”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The sample included children with a range of tics and associated impairment as well as co-occurring psychiatric conditions, suggesting that the study results are applicable to clinical populations of children with moderate to severe Tourette disorder.”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 92 claims and to verify the 40 references still open.
- It may state two separate claims as one. 34
- Probably not a substantial claim. 33
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tic severity was reduced by 26–31% (as measured by the YGTSS-TTS)”
From European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Behavior therapy (e.g., habit reversal training, comprehensive behavioral intervention for tics) has also demonstrated efficacy in reducing tic symptom severity in RCTs for youth and adults (Piacentini et al., 2010; Himle et al., 2012; Wilhelm et al., 2012)”
From Living with tics: Reduced impairment and improved quality of life for youth with chronic tic disorders (2015) · cites this paper as Piacentini et al., 2010
In the citing paper
“The largest RCT evaluated CBIT in 126 children (9–17 years) with TS or CTD [8].”
From European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions (2022) · cites this paper as [8]
In the citing paper
“However, as a stand-alone intervention aimed at reducing tic severity, psychoeducation (sometimes also extended with information on healthy habits and common comorbid conditions, and referred to as psychoeducation and supportive psychotherapy [PST]) has been shown inferior to BT and PT in several RCTs [8, 14, 15].”
From European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions (2022) · cites this paper as [8]
In the citing paper
“In this study, CBIT was superior to psychoeducation and PST in reducing tic severity (as measured by the Yale Global Tic Severity Scale - Total Tic Severity Score [YGTSS-TTS]; effect size: 0.68, as compared to PST).”
From European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions (2022) · cites this paper as [8]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Outcomes
“a 30% decline (23.4 to 16.4) for the control treatment”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Discussion
“the control treatment was associated with a 31% decrease in tic-related impairment.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Treatment Durability
“In the PST group, all 12 classified as positive responders at Week 10 returned for assessment at 3 months and 8 returned at 6 months post-treatment.”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Treatment Durability
“In the PST group, 6 of 12 children (50%) showed continued benefit (6 were lost to follow up).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Results > Baseline Characteristics
“Overall, 36.5% of children entered the trial on stable anti-tic medication.”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Discussion
“38% of children in our study were taking stable tic-suppressing medication at study entry.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Abstract > Main Outcome Measures
“Yale Global Tic Severity Scale (range 0–40, score >15 indicating clinically significant tics)”
§ Behavior Therapy for Children with Tourette Disorder: A Randomized Controlled Trial > Methods > Outcome Measures
“a combined Total Tic score (range 0–50)”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716 · cited 2×
“Functional status was also assessed with the clinician-rated Children’s Global Assessment Scale (score 0-100).(23) Scores of 60 or lower indicate a need for treatment; scores above 70 reflect normal functioning.”
Aldenderfer, M. S., & Blashfield, R. K. (1984) · Cited by 2,358
The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Self-citationCognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442
Self-citationFUNCTIONAL ANALYSIS OF PROBLEM BEHAVIOR: A REVIEW
Hanley, G. P., Iwata, B. A., & McCord, B. E. (2003) · Journal of Applied Behavior Analysis · doi:10.1901/jaba.2003.36-147 · Cited by 1,317
Applied Mixed Models in Medicine
Brown, H., & Presco, R. (2000) · Technometrics · doi:10.1080/00401706.2000.10485742 · Cited by 1,262
SWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157
Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915020-00003 · Cited by 903
Premonitory urges in Tourette's syndrome
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.98 · Cited by 628
Kalanithi, P. S. A., Zheng, W., Kataoka, Y., DiFiglia, M., Grantz, H., Saper, C. B., Schwartz, M. L., Leckman, J. F., & Vaccarino, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502624102 · Cited by 551
Jankovic, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010032 · Cited by 447
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Self-citationZiprasidone Treatment of Children and Adolescents With Tourette's Syndrome: A Pilot Study
SALLEE, F. R., KURLAN, R., GOETZ, C. G., SINGER, H., SCAHILL, L., LAW, G., DITTMAN, V. M., & CHAPPELL, P. B. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200003000-00010 · Cited by 341
Self-citationContemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
Self-citationMissing data in randomised controlled trials: a practical guide
Carpenter, J. R., & Kenward, M. (2007) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 285
Church, J. A., Fair, D. A., Dosenbach, N. U. F., Cohen, A. L., Miezin, F. M., Petersen, S. E., & Schlaggar, B. L. (2009) · Brain · doi:10.1093/brain/awn223 · Cited by 278
Wilhelm, S., Deckersbach, T., Coffey, B. J., Bohne, A., Peterson, A. L., & Baer, L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1175 · Cited by 252
Self-citationThe influence of contextual factors on tic expression in Tourette's syndrome: A review
Conelea, C. A., & Woods, D. W. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.04.010 · Cited by 249
Self-citationPrevalence of tic disorders and Tourette syndrome in a Swedish school population
Khalifa, N., & von Knorring, A.-L. (2003) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162203000598 · Cited by 242
Phenomenology of tics and natural history of tic disorders
Leckman, J. F. (2003) · Brain and Development · doi:10.1016/s0387-7604(03)90004-0 · Cited by 227
(2009) · PsycEXTRA Dataset · doi:10.1037/e551952010-002 · Cited by 225
Risperidone Versus Clonidine in the Treatment of Children and Adolescents With Tourette's Syndrome
GAFFNEY, G. R., PERRY, P. J., LUND, B. C., BEVER-STILLE, K. A., ARNDT, S., & KUPERMAN, S. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00013 · Cited by 223
Mink, J. W. (2006) · PubMed · Cited by 207
Jankovic, J., Jimenez-Shahed, J., & Brown, L. W. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.185348 · Cited by 193
Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies
Marsh, R., Maia, T. V., & Peterson, B. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08091354 · Cited by 187
Neural correlates of tic severity and cognitive control in children with Tourette syndrome
Baym, C. L., Corbett, B. A., Wright, S. B., & Bunge, S. A. (2008) · Brain · doi:10.1093/brain/awm278 · Cited by 186
Brief Review of Habit Reversal Training for Tourette Syndrome
Himle, M. B., Woods, D. W., Piacentini, J. C., & Walkup, J. T. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210080101 · Cited by 183
Self-citationMiguel, E. C., Coffey, B. J., Baer, L., Savage, C. R., Rauch, S. L., & Jenike, M. A. (1995) · PubMed · Cited by 176
Tic Reduction With Risperidone Versus Pimozide in a Randomized, Double-Blind, Crossover Trial
Gilbert, D. L., Batterson, J. R., Sethuraman, G., & Sallee, F. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200402000-00017 · Cited by 158
A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome
Ross, M. S., & Moldofsky, H. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.5.585 · Cited by 158
Leung, P. (1999) · Journal of Technology in Human Services · doi:10.1300/j407v15n04_06 · Cited by 153
Evidence-based psychosocial treatments for tic disorders.
Cook, C. R., & Blacher, J. (2007) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2007.00085.x · Cited by 130
Brief Review of Habit Reversal Training for Tourette Syndrome
Mack, A. H. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79325-3 · Cited by 129
Phenomenology of tics and natural history of tic disorders.
Leckman, J. F., Peterson, B. S., King, R. A., Scahill, L. D., & Cohen, D. J. (2001) · PubMed · Cited by 119
Self-citationChang, S., Himle, M. B., Tucker, B. T. P., Woods, D. W., & Piacentini, J. (2009) · Child & Family Behavior Therapy · doi:10.1080/07317100903099100 · Cited by 100
Self-citationA treatment model for motor tics based on a specific tension-reduction technique
Evers, R., & van de Wetering, B. J. M. (1994) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(94)90026-4 · Cited by 97
A Cursing Brain? The Histories of Tourette Syndrome
Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1748 · Cited by 97
The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome.
Graybiel, A. M., & Canales, J. J. (2001) · PubMed · Cited by 90
Successful Treatment of the Maladie des Tics: Gilles de la Tourette's Syndrome
Stevens, J. R., & Blachly, P. H. (1966) · American journal of diseases of children · doi:10.1001/archpedi.1966.02090150085006 · Cited by 50
Watson, T. S., Dufrene, B. A., Weaver, A. D., Butler, T. S., & Meeks, C. (2005) · Behavior Modification · doi:10.1177/0145445505279252 · Cited by 44
Treatment-generated problems associated with behavior modification in Tourette disorder.
Burd, L., & Kerbeshian, J. (1987) · PubMed · Cited by 34
Gilbert, D. L., & Buncher, C. R. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.3.324 · Cited by 26
Goetz, C. G., & Horn, S. S. (2004) · Neurological disease and therapy · doi:10.1201/b14236-21 · Cited by 5
Research works printed but not linked: 5
- [4]Woods D Marcks B Flessner C Woods D Piacentini J Walkup JT Management of social and occupational difficulties in persons with Tourette syndrom Treating Tourette Syndrome and Tic Disorders 2007 NY Guilford Press 265 278
- [11]Conelea CA Woods DW The role of contextual factors in tic expression J Psychosom Res 2008 65 487 496 18940379
- [12]Woods DW Piacentini JC Chang S Managing Tourette’s Syndrome: A Behavioral Intervention for Children and Adults 2008 New York Oxford University Press
- [15]Peterson A Woods DW Piacentini JC Walkup JT Psychosocial management of tics and intentional repetitive behaviors associated with Tourette syndrome Treating Tourette Syndrome and Tic Disorders: A Guide for Practitioners 2007 New York The Guilford Press 154 184
- [20]Albano AM Silverman WK The anxiety disorders interview schedule for DSM-IV, child version: clinician manual 1996 New York Oxford University Press
Cited by
Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry
Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S., & Ersche, K. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.009 · Cited by 1,003
Gilles de la Tourette syndrome
Robertson, M. M., Eapen, V., Singer, H. S., Martino, D., Scharf, J. M., Paschou, P., Roessner, V., Woods, D. W., Hariz, M., Mathews, C. A., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.97 · Cited by 347
Self-citationA meta-analysis of behavior therapy for Tourette Syndrome
McGuire, J. F., Piacentini, J., Brennan, E. A., Lewin, A. B., Murphy, T. K., Small, B. J., & Storch, E. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.009 · Cited by 334
Self-citationRandomized Trial of Behavior Therapy for Adults With Tourette Syndrome
Wilhelm, S., Peterson, A. L., Piacentini, J., Woods, D. W., Deckersbach, T., Sukhodolsky, D. G., Chang, S., Liu, H., Dziura, J., Walkup, J. T., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1528 · Cited by 330
Self-citationthe ESSTS Guidelines Group, Verdellen, C., van de Griendt, J., Hartmann, A., & Murphy, T. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0167-3 · Cited by 328
Metadata
- Authors
- Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., & Walkup, J. T.
- Affiliations
- University of California, Los Angeles (US)
- University of Wisconsin–Milwaukee (US)
- Yale University (US)
- Harvard University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Johns Hopkins University (US)
- Tourette Association of America (US)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-19
- Volume
- 303
- Issue
- 19
- Pages
- 1929
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC2993317
- OpenAlex
- W2017520416
- Semantic Scholar
- ccc4c348d0654d27fb9e45746e43e6c5f1b9e29a
- Cited by
- 790
- References
- 46
- Citations by year
- 2026: 40 · 2025: 43 · 2024: 43 · 2023: 39 · 2022: 56 · 2021: 57 · 2020: 62 · 2019: 39 · 2018: 51 · 2017: 48 · 2016: 50 · 2015: 49 · 2014: 56 · 2013: 44 · 2012: 54
- FWCI
- 49.48
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K23MH080914, R01MH070802)
- National Center for Research Resources (UL1RR024139)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Clinical Psychology › Stuttering Research and Treatment
- Keywords
- Tourette syndrome, chronic tic disorders, behavior therapy, tic severity, children and adolescents, Yale Global Tic Severity Scale, antipsychotic adverse effects, treatment durability, booster sessions, treatment discontinuation, number needed to treat, treatment acceptability, medication adherence
- MeSH terms
- Adolescent, Behavior Therapy, Child, Female, Tourette Syndrome, Humans, Male, Severity of Illness Index, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.